Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Pricing
Rankings
For Publishers
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Pricing
Rankings
For Publishers
Log In
Start Free Trial
Maria Letizia Cataldo
Sign up to set email alerts
44
Publications
412
Citation Statements Received
606
Citation Statements Given
How they've been cited
578
19
392
1
How they cite others
1,654
39
566
1
Affiliations
Baylor College of Medicine
,
Dan L Duncan Comprehensive Cancer Center
Publications
Order By: Most citations
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer
Fu
1
,
Pereira
2
,
De Angelis
3
et al.
2019
Proc. Natl. Acad. Sci. U.S.A.
Abstract
Show
188
9
142
0
Get article
Add to collection
Cite
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer
De Angelis
1
,
Fu
2
,
Cataldo
3
et al.
2021
Abstract
Show
111
7
99
0
2
Get article
Add to collection
Cite
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy
De Angelis
1
,
Nagi
2
,
Hoyt
3
et al.
2020
Abstract
Show
103
1
47
0
Get article
Add to collection
Cite
The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance
Nardone
1
,
Weir
2
,
Delpuech
3
et al.
2018
Br J Cancer
Abstract
Show
69
0
45
1
Get article
Add to collection
Cite
NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer
Bhat
1
,
Thangavel
2
,
Abdulkareem
3
et al.
2022
Sci Rep
Abstract
Show
31
0
22
0
Get article
Add to collection
Cite
The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer
Cataldo
1
,
De Placido
2
,
Esposito
3
et al.
2023
Front. Oncol.
Abstract
Show
20
0
15
0
Get article
Add to collection
Cite
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
Fu
1
,
Pereira
2
,
Liu
3
et al.
2023
Cell Reports
29
1
8
0
Get article
Add to collection
Cite
Abstract GS2-01: High levels of interferon-response gene signatures are associated with
de novo
and acquired resistance to CDK4/6 inhibitors in ER+ breast cancer
De Angelis
1
,
Fu
2
,
Cataldo
3
et al.
2020
Abstract
Show
5
1
5
0
Get article
Add to collection
Cite
1
2
3
4